CEO Lewis Joel Sells 56K Shares of Galectin Therapeutics Amid Rising Market Volatility.
CEO Lewis Joel sells 56k Galectin Therapeutics shares—what the move means for insider confidence, liquidity, and the company’s future.
4 minutes to read
Galectin Therapeutics Inc